P1047: REAL-WORLD SAFETY OF RUXOLITINIB IN PATIENTS WITH INTERMEDIATE OR HIGH RISK OF PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS IN CHINA

• Z. Xu,
• M. Duan,
• Q. Jiang,
• Q. Leng,
• N. Xu,
• Y. Zhang,
• C. Zhao,
• W. Wu,
• Q. Zhang,
• J. Fu,
• J. Zhang,
• R. Fu,
• Z. Yan,
• J. Zhang,
• C. Lin,
• G. Ouyang,
• Z. Wang,
• L. Ma,
• H. Hao,
• X. Li,
• S. Ran,
• Y. Chen,
• T. Li,
• Z. Xiao

Affiliations

Z. Xu

1 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin

M. Duan

2 Peking Union Medical College Hospital

Q. Jiang

3 Peking University People’s Hospital, Beijing

Q. Leng

4 Anshan Central Hospital, Liaoning

N. Xu

5 Nanfang Hospital, Southern Medical University, Guangdong

Y. Zhang

6 Henan Provincial People’s Hospital, Henan

C. Zhao

7 Affiliated Hospital of Qingdao University, Shandong

W. Wu

8 Ruijin Hospital, Shanghai Jiao Tong University, Shanghai

Q. Zhang

9 Gansu Provincial People’s Hospital, Gansu

J. Fu

10 Shaoxing People’s Hospital, Zhejiang

J. Zhang

11 The Second Hospital of Hebei Medical University, Hebei

R. Fu

12 Tianjin Medical University General Hospital, Tianjin

Z. Yan

13 North China University of Technology Affiliated Hospital, Hebei

J. Zhang

14 Nanchang University Affiliated Ganzhou Hospital, Jiangxi

C. Lin

15 Zhangzhou Affiliated Hospital of Fujian Medical University, Fujian

G. Ouyang

16 Ningbo First Hospital, Zhejiang

Z. Wang

17 Wuxi Second People’s Hospital, Jiangsu

L. Ma

18 Sun Yat Sen Memorial Hospital of Sun Yat Sen University, Guangdong

H. Hao

19 Hebei General Hospital, Hebei

X. Li

20 Affiliated Hospital of Southwest Medical University, Sichuan

S. Ran

21 Beijing Novartis Pharma Co., Ltd, Beijing

Y. Chen

22 China Novartis Institutes For Biomedical Research Co., Ltd

T. Li

23 China Novartis Institutes For Biomedical Research Co., Ltd., Shanghai, China

Z. Xiao

1 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin